Csenge Advisory Group bought a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the 4th quarter, HoldingsChannel reports. The institutional investor bought 7,784 shares of the company’s stock, valued at approximately $1,295,000.
Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Vanguard Group Inc. increased its holdings in shares of Astera Labs by 14.1% during the 3rd quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock worth $2,690,907,000 after purchasing an additional 1,693,918 shares during the period. Amundi lifted its stake in shares of Astera Labs by 1,298.6% in the third quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after buying an additional 1,319,643 shares during the period. Rafferty Asset Management LLC acquired a new stake in Astera Labs during the third quarter worth about $209,599,000. BNP Paribas Financial Markets increased its stake in Astera Labs by 577.3% during the third quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock valued at $220,733,000 after acquiring an additional 960,899 shares during the period. Finally, Voloridge Investment Management LLC acquired a new position in Astera Labs in the 3rd quarter valued at approximately $131,539,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.
Astera Labs Price Performance
ALAB opened at $287.48 on Thursday. The stock has a market capitalization of $49.28 billion, a P/E ratio of 194.24, a price-to-earnings-growth ratio of 3.23 and a beta of 3.35. The company’s 50 day simple moving average is $163.12 and its 200-day simple moving average is $157.97. Astera Labs, Inc. has a one year low of $84.78 and a one year high of $287.70.
Wall Street Analyst Weigh In
ALAB has been the topic of several recent research reports. Barclays lifted their price objective on Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. UBS Group initiated coverage on Astera Labs in a research report on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 target price for the company. Roth Mkm reiterated a “buy” rating and set a $275.00 price target on shares of Astera Labs in a research note on Wednesday, May 6th. Morgan Stanley boosted their price target on shares of Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Finally, TD Cowen increased their price objective on shares of Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research note on Wednesday, May 6th. Fifteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to data from MarketBeat, Astera Labs currently has an average rating of “Moderate Buy” and an average target price of $233.75.
Read Our Latest Stock Analysis on ALAB
Key Stories Impacting Astera Labs
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Wall Street optimism and a fresh analyst “buy” call helped fuel the rally, with investors viewing Astera Labs as a strong AI play. Astera Labs (ALAB) Soars 13% on Analyst ‘Buy’ Reco
- Positive Sentiment: Management commentary about a new switch timeline and potential revenue opportunities in optical networking boosted sentiment around future growth catalysts. Here’s why Astera Labs’ stock just staged a big gain
- Positive Sentiment: Traders also pointed to a “Power Inflow” alert and unusually heavy call-option buying, suggesting aggressive bullish positioning and momentum chasing in the stock. Astera Labs Shares Rise Over 6 Percent After Key Trading Signal
- Positive Sentiment: The stock is also being bid up after a Barron’s report said it is on pace for a record high, reinforcing the market’s view that Astera Labs is emerging as a notable AI infrastructure winner. Astera Labs Stock on Pace for Record High. Why It’s Up Double Digits for a Second Day.
Insider Transactions at Astera Labs
In related news, COO Sanjay Gajendra sold 95,444 shares of Astera Labs stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $225.02, for a total value of $21,476,808.88. Following the completion of the sale, the chief operating officer directly owned 1,435,857 shares in the company, valued at $323,096,542.14. This trade represents a 6.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Jitendra Mohan sold 28,737 shares of the business’s stock in a transaction dated Tuesday, May 19th. The stock was sold at an average price of $249.62, for a total value of $7,173,329.94. Following the sale, the chief executive officer directly owned 3,789,232 shares of the company’s stock, valued at $945,868,091.84. This represents a 0.75% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 1,635,461 shares of company stock worth $288,735,776. Insiders own 12.50% of the company’s stock.
Astera Labs Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Articles
- Five stocks we like better than Astera Labs
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
